Physician profile
Katherine G Eppler
NPI 1275633471
$789.26
in general payments reported to CMS, 2019-2025
14 companies · $78.47 in 2025
The $78.47 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.33 · 2022: $205 · 2023: $258 · 2024: $177 · 2025: $78.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $170.60 | 2023-2025 | |
| Abbvie INC. | $144.43 | 2022-2023 | |
| Coopersurgical, INC. | $73.92 | 2021-2023 | Paragard T 380a |
| Exeltis, USA INC. | $67.29 | 2022-2023 | Tyblume |
| Avion Pharmaceuticals | $65.21 | 2021-2022 | |
| Hologic Sales and Service, LLC | $54.03 | 2024 | Aptima |
| Shield Therapeutics INC | $41.29 | 2023 | Accrufer |
| Millicent US INC | $35.83 | 2025 | Femlyv, Intrarosa, Femring |
| Agile Therapeutics, INC. | $27.20 | 2021-2023 | Twirla |
| Daiichi Sankyo INC. | $25.55 | 2024 | Injectafer |
| Pfizer INC. | $22.28 | 2024 | |
| Organon LLC | $21.71 | 2025 | Nexplanon |
| Lupin INC. | $20.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.67 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Eppler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.